The Phase 3 INVIGORATE Trial of Reproxalap in Patients with Seasonal Allergic Conjunctivitis

The Phase 3 INVIGORATE Trial of Reproxalap in Patients with Seasonal Allergic Conjunctivitis

Christopher E Starr,1 Kelly K Nichols,2 Jacob R Lang,3 Todd C Brady4 1Department of Ophthalmology, Weill Cornell Medicine, New York, NY, USA; 2School of Optometry, University of Alabama, Birmingham, AL, USA; 3College of Optometry, the Ohio State University, Columbus, OH, USA; 4Aldeyra Therapeutics,...

Full description

Bibliographic Details
Main Authors: Starr CE, Nichols KK, Lang JR, Brady TC
Format: Article
Language:English
Published: Dove Medical Press 2023-12-01
Series:Clinical Ophthalmology
Subjects:
allergic conjunctivitis
reactive aldehyde species
reproxalap
ocular itching
ocular redness
Online Access:https://www.dovepress.com/the-phase-3-invigorate-trial-of-reproxalap-in-patients-with-seasonal-a-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/the-phase-3-invigorate-trial-of-reproxalap-in-patients-with-seasonal-a-peer-reviewed-fulltext-article-OPTH

Similar Items